SlideShare a Scribd company logo
Medical countermeasures for
dangerous pathogens
Andrew Scott, PhD
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
1
Corporate information
‘The Defence Science and Technology Laboratory
ensures that innovative science and technology
contribute to the defence and security of the UK’
•Identify and monitor national security risks and
opportunities
•Protect the UK and our interests at home, at our border,
and internationally, in order to address physical and
electronic threats from state and non-state sources
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
2
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
Portsdown West
Porton Down
Fort Halstead
Corporate information
3
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
Analysis CBR Systems
C4ISR
Counter Terrorism
and Security Cyber
Human Capability
Integrated
Survivability Weapons
Corporate capabilities
4
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
Corporate capabilities
Analysis CBR Systems
C4ISR
Counter Terrorism
and Security Cyber
Human Capability
Integrated
Survivability Weapons
‘Provides an integrated Chemistry, Biology, Radiation
and Medical Sciences capability’
CBR Division
54
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
CBR Division
Modelling, hazard
assessment, advice
Physical protection
Decontamination
and disposal
Detection and
diagnosisMedical
countermeasures
6
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
7
Biodefence pathogens
•Intra-cellular
pathogens
•More serious disease
if inhaled
•Symptoms are generic
•Insensitive to antibiotics
•Treatment is prolonged / requires
IV administration
Tularaemia
Melioidosis
Glanders
Plague
Ebola
Anthrax
© Crown copyright 2016 Dstl
28 September 2016
UK OFFICIAL
•Establish an in-depth knowledge of each biological agent
•Develop novel medical countermeasures active against
biological warfare (BW) agents
•Test the effectiveness of those countermeasures in the
most appropriate in vitro and in vivo models.
BW MedCM Programme
8
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
Microbiology group
•Containment Level 2, 3 and 4 laboratories
•Handling and manipulation of high-containment
pathogens
•Animal models of disease
9
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
10
Bio Medical Countermeasures Projects
BROAD
Target discovery and
early stage progression
of small molecule
MedCMs
AMIC
Engagement with
industry and evaluation
of more developed
candidate MedCMs
iMAT
Development of key
infection models and
progression of non
traditional therapies
Broad-spectrum antimicrobials
© Crown copyright 2016 Dstl
28 September 2016
• Conduct fundamental research into the
biology of biothreat agents
• Stimulate development of novel
antimicrobials against novel targets
• Align defence needs with public health
UK OFFICIAL 11
Transposon-Directed mutagenesis
– Generation of super-saturated transposon libraries
Insertion-site Sequencing
– Uses next-gen sequencing technology
– Sequence all mutants present within one experiment
• T
• I
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
TraDIS
KanR KanR
Transposase
Random insertion
and gene tagged
Transposon
Gene B = essential
bacteria dies
Gene B = non-essential
bacteria survives
12
Transposome
complex
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
Moule et al. (2014) Mbio 5: e00926-13
TraDIS
• Absence of insertions
13
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
TraDIS
Burkholderia
pseudomallei
Yersinia
pestis
Francisella
tularensis
Yp Ft
Bp
• Conservation across other
biothreat pathogens
• Conservation across ESKAPEE
pathogens
• Identification of human
homologues
• Informatics (druggability, assay
availability, previous development)
148 targets to exploit
148
14
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
TraDIS for disease related targets
15
• Library of mutants
• Infection
• Recover bacteria
Gene A Gene B Gene C Gene D Gene E
Gene A Gene B Gene C Gene D Gene E
Quantitative
sequencing
Quantitative
sequencing
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
16
284 genes negatively
selected at 24 hours
TraDIS for disease related targets
Next steps…
© Crown copyright 2016 Dstl
28 September 2016
UK OFFICIAL 17
Validate relevance
in disease
Understand target function
target in the pathogen
Generate tools to support
future drug discovery efforts
Norville et al. (2011) Infect. Imm. 79, 4299-4307Custodio et al. (2016) Mol. Micro. doi: 10.1111/mmi.13531. [Epub ahead of print]
UK OFFICIAL© Crown copyright 2016 Dstl
28 September 2016
18
Bio Medical Countermeasures Projects
BROAD
Target discovery and
early stage progression
of small molecule
MedCMs
AMIC
Engagement with
industry and evaluation
of more developed
candidate MedCMs
iMAT
Development of key
infection models and
progression of non
traditional therapies
© Crown copyright 2016 Dstl
28 September 2016
UK OFFICIAL 19
Summary
Stimulating
target
development
Pulling
compounds
through

More Related Content

What's hot

Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
NHShcs
 
MRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics DiscoveryMRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics Discovery
warwick_amr
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
KTN
 
HCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike RasenbergHCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike Rasenberg
Chemicals Forum Association
 
Identification, prioritization and conduct of applied research and analyses i...
Identification, prioritization and conduct of applied research and analyses i...Identification, prioritization and conduct of applied research and analyses i...
Identification, prioritization and conduct of applied research and analyses i...
EFSA EU
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De Schamphelaere
Chemicals Forum Association
 
Project Roadmap 2016-2020 - Chris Arnold
Project Roadmap 2016-2020 - Chris ArnoldProject Roadmap 2016-2020 - Chris Arnold
Project Roadmap 2016-2020 - Chris Arnold
Human Variome Project
 
HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas Ball
Chemicals Forum Association
 
Using system dynamics for ex-ante impact assessment of food safety policies i...
Using system dynamics for ex-ante impact assessment of food safety policies i...Using system dynamics for ex-ante impact assessment of food safety policies i...
Using system dynamics for ex-ante impact assessment of food safety policies i...
ILRI
 
Introduction to the SBRI Competition: Vaccines for Epidemic Diseases
Introduction to the SBRI Competition: Vaccines for Epidemic DiseasesIntroduction to the SBRI Competition: Vaccines for Epidemic Diseases
Introduction to the SBRI Competition: Vaccines for Epidemic Diseases
KTN
 
The Wellcome Trust - Margaret Hurley
The Wellcome Trust - Margaret HurleyThe Wellcome Trust - Margaret Hurley
The Wellcome Trust - Margaret HurleyOpenExeter
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de Bruijn
Chemicals Forum Association
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
jangeissler
 
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpointCadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
CADTH Symposium
 
Cyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. LedererCyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. Lederer
Human Variome Project
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
jangeissler
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
jangeissler
 
Pam Kearns: How can I do my Clinical Trial?
Pam Kearns: How can I do my Clinical Trial? Pam Kearns: How can I do my Clinical Trial?
Pam Kearns: How can I do my Clinical Trial? mds-rkto
 
Update on local and national survivorship initiatives
Update on local and national survivorship initiativesUpdate on local and national survivorship initiatives
Update on local and national survivorship initiatives
UCLPartners
 

What's hot (20)

Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
 
MRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics DiscoveryMRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics Discovery
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
 
HCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike RasenbergHCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike Rasenberg
 
Identification, prioritization and conduct of applied research and analyses i...
Identification, prioritization and conduct of applied research and analyses i...Identification, prioritization and conduct of applied research and analyses i...
Identification, prioritization and conduct of applied research and analyses i...
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De Schamphelaere
 
Project Roadmap 2016-2020 - Chris Arnold
Project Roadmap 2016-2020 - Chris ArnoldProject Roadmap 2016-2020 - Chris Arnold
Project Roadmap 2016-2020 - Chris Arnold
 
HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas Ball
 
Using system dynamics for ex-ante impact assessment of food safety policies i...
Using system dynamics for ex-ante impact assessment of food safety policies i...Using system dynamics for ex-ante impact assessment of food safety policies i...
Using system dynamics for ex-ante impact assessment of food safety policies i...
 
Introduction to the SBRI Competition: Vaccines for Epidemic Diseases
Introduction to the SBRI Competition: Vaccines for Epidemic DiseasesIntroduction to the SBRI Competition: Vaccines for Epidemic Diseases
Introduction to the SBRI Competition: Vaccines for Epidemic Diseases
 
The Wellcome Trust - Margaret Hurley
The Wellcome Trust - Margaret HurleyThe Wellcome Trust - Margaret Hurley
The Wellcome Trust - Margaret Hurley
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de Bruijn
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
 
Project Roadmap 2012-2016
Project Roadmap 2012-2016Project Roadmap 2012-2016
Project Roadmap 2012-2016
 
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpointCadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
Cadth 2015 c5 2. lacaze cadth symposium 2015 powerpoint
 
Cyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. LedererCyprus: a case study - Carsten W. Lederer
Cyprus: a case study - Carsten W. Lederer
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
Pam Kearns: How can I do my Clinical Trial?
Pam Kearns: How can I do my Clinical Trial? Pam Kearns: How can I do my Clinical Trial?
Pam Kearns: How can I do my Clinical Trial?
 
Update on local and national survivorship initiatives
Update on local and national survivorship initiativesUpdate on local and national survivorship initiatives
Update on local and national survivorship initiatives
 

Viewers also liked

Oracle UCM Security: Challenges and Best Practices
Oracle UCM Security: Challenges and Best PracticesOracle UCM Security: Challenges and Best Practices
Oracle UCM Security: Challenges and Best Practices
Brian Huff
 
Patent Risk and Countermeasures Related to Open Management in Interaction Design
Patent Risk and Countermeasures Related to Open Management in Interaction DesignPatent Risk and Countermeasures Related to Open Management in Interaction Design
Patent Risk and Countermeasures Related to Open Management in Interaction Design
Yosuke Sakai
 
Antivirus Evasion Techniques and Countermeasures
Antivirus  Evasion Techniques and CountermeasuresAntivirus  Evasion Techniques and Countermeasures
Antivirus Evasion Techniques and Countermeasures
securityxploded
 
Skyjacking A Cisco Wlan Attack Analysis And Countermeasures
Skyjacking A Cisco Wlan Attack Analysis And CountermeasuresSkyjacking A Cisco Wlan Attack Analysis And Countermeasures
Skyjacking A Cisco Wlan Attack Analysis And Countermeasures
AirTight Networks
 
Email phishing and countermeasures
Email phishing and countermeasuresEmail phishing and countermeasures
Email phishing and countermeasures
Jorge Sebastiao
 
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
Jeremiah Grossman
 
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
International Atomic Energy Agency
 
Cehv8 module 01 introduction to ethical hacking
Cehv8 module 01 introduction to ethical hackingCehv8 module 01 introduction to ethical hacking
Cehv8 module 01 introduction to ethical hacking
polichen
 
Seminar Presentation
Seminar PresentationSeminar Presentation
Seminar Presentation
Sergey Rubinsky, Ph.D.
 
VoIP: Attacks & Countermeasures in the Corporate World
VoIP: Attacks & Countermeasures in the Corporate WorldVoIP: Attacks & Countermeasures in the Corporate World
VoIP: Attacks & Countermeasures in the Corporate World
Jason Edelstein
 
Bone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
Bone Loss in Long-Duration Spaceflight: Measurements and CountermeasuresBone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
Bone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
American Astronautical Society
 
Iis Security Programming Countermeasures
Iis Security Programming CountermeasuresIis Security Programming Countermeasures
Iis Security Programming Countermeasuresguestc27cd9
 
Return oriented programming
Return oriented programmingReturn oriented programming
Return oriented programming
hybr1s
 
Digital Astroturfing: Definition, typology, and countermeasures.
Digital Astroturfing: Definition, typology, and countermeasures.Digital Astroturfing: Definition, typology, and countermeasures.
Digital Astroturfing: Definition, typology, and countermeasures.
Marko Kovic
 
Designing Countermeasures For Tomorrows Threats
Designing Countermeasures For Tomorrows ThreatsDesigning Countermeasures For Tomorrows Threats
Designing Countermeasures For Tomorrows Threats
Darwish Ahmad
 
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
Alonso Caballero
 
Google Hacking for Cryptographic Secrets
Google Hacking for Cryptographic SecretsGoogle Hacking for Cryptographic Secrets
Google Hacking for Cryptographic SecretsDr. Emin İslam Tatlı
 
Irregularity Countermeasures in Massively Parallel BigData Processors
Irregularity Countermeasures in Massively Parallel BigData ProcessorsIrregularity Countermeasures in Massively Parallel BigData Processors
Irregularity Countermeasures in Massively Parallel BigData Processors
Tokyo University of Science
 
Owasp Top 10 And Security Flaw Root Causes
Owasp Top 10 And Security Flaw Root CausesOwasp Top 10 And Security Flaw Root Causes
Owasp Top 10 And Security Flaw Root CausesMarco Morana
 
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
CODE BLUE
 

Viewers also liked (20)

Oracle UCM Security: Challenges and Best Practices
Oracle UCM Security: Challenges and Best PracticesOracle UCM Security: Challenges and Best Practices
Oracle UCM Security: Challenges and Best Practices
 
Patent Risk and Countermeasures Related to Open Management in Interaction Design
Patent Risk and Countermeasures Related to Open Management in Interaction DesignPatent Risk and Countermeasures Related to Open Management in Interaction Design
Patent Risk and Countermeasures Related to Open Management in Interaction Design
 
Antivirus Evasion Techniques and Countermeasures
Antivirus  Evasion Techniques and CountermeasuresAntivirus  Evasion Techniques and Countermeasures
Antivirus Evasion Techniques and Countermeasures
 
Skyjacking A Cisco Wlan Attack Analysis And Countermeasures
Skyjacking A Cisco Wlan Attack Analysis And CountermeasuresSkyjacking A Cisco Wlan Attack Analysis And Countermeasures
Skyjacking A Cisco Wlan Attack Analysis And Countermeasures
 
Email phishing and countermeasures
Email phishing and countermeasuresEmail phishing and countermeasures
Email phishing and countermeasures
 
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
Identifying Web Servers: A First-look Into the Future of Web Server Fingerpri...
 
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
Table 4: Unit 4 Reactor: Fukushima Daiichi Nuclear Power Plant - 18 May 2011
 
Cehv8 module 01 introduction to ethical hacking
Cehv8 module 01 introduction to ethical hackingCehv8 module 01 introduction to ethical hacking
Cehv8 module 01 introduction to ethical hacking
 
Seminar Presentation
Seminar PresentationSeminar Presentation
Seminar Presentation
 
VoIP: Attacks & Countermeasures in the Corporate World
VoIP: Attacks & Countermeasures in the Corporate WorldVoIP: Attacks & Countermeasures in the Corporate World
VoIP: Attacks & Countermeasures in the Corporate World
 
Bone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
Bone Loss in Long-Duration Spaceflight: Measurements and CountermeasuresBone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
Bone Loss in Long-Duration Spaceflight: Measurements and Countermeasures
 
Iis Security Programming Countermeasures
Iis Security Programming CountermeasuresIis Security Programming Countermeasures
Iis Security Programming Countermeasures
 
Return oriented programming
Return oriented programmingReturn oriented programming
Return oriented programming
 
Digital Astroturfing: Definition, typology, and countermeasures.
Digital Astroturfing: Definition, typology, and countermeasures.Digital Astroturfing: Definition, typology, and countermeasures.
Digital Astroturfing: Definition, typology, and countermeasures.
 
Designing Countermeasures For Tomorrows Threats
Designing Countermeasures For Tomorrows ThreatsDesigning Countermeasures For Tomorrows Threats
Designing Countermeasures For Tomorrows Threats
 
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
Webinar Gratuito: "Herramientas Graficas en Kali Linux 2.0"
 
Google Hacking for Cryptographic Secrets
Google Hacking for Cryptographic SecretsGoogle Hacking for Cryptographic Secrets
Google Hacking for Cryptographic Secrets
 
Irregularity Countermeasures in Massively Parallel BigData Processors
Irregularity Countermeasures in Massively Parallel BigData ProcessorsIrregularity Countermeasures in Massively Parallel BigData Processors
Irregularity Countermeasures in Massively Parallel BigData Processors
 
Owasp Top 10 And Security Flaw Root Causes
Owasp Top 10 And Security Flaw Root CausesOwasp Top 10 And Security Flaw Root Causes
Owasp Top 10 And Security Flaw Root Causes
 
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
[CB16] Air-Gap security: State-of-the-art Attacks, Analysis, and Mitigation b...
 

Similar to Dstl Medical Countermeasures for Dangerous Pathogens

The code of conduct the IPT initiative
The code of conduct the IPT initiativeThe code of conduct the IPT initiative
The code of conduct the IPT initiative
Pasteur_Tunis
 
Impact Through Innovation: The Wellcome Sanger Institute
Impact Through Innovation: The Wellcome Sanger InstituteImpact Through Innovation: The Wellcome Sanger Institute
Impact Through Innovation: The Wellcome Sanger Institute
Victoria Lebedeva- Baxter ACIM
 
PM Briefings from 9 Feb 2016 Innovation Network event
PM Briefings from 9 Feb 2016 Innovation Network eventPM Briefings from 9 Feb 2016 Innovation Network event
PM Briefings from 9 Feb 2016 Innovation Network event
Defence and Security Accelerator
 
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
John Blue
 
Dr. Alex Morrow - Global Coordination of Animal Disease Research
Dr. Alex Morrow - Global Coordination of Animal Disease ResearchDr. Alex Morrow - Global Coordination of Animal Disease Research
Dr. Alex Morrow - Global Coordination of Animal Disease Research
John Blue
 
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
John Blue
 
11. political and regulatory aspects of veterinary antibiotics use in europe
11. political and regulatory aspects of veterinary antibiotics use in europe11. political and regulatory aspects of veterinary antibiotics use in europe
11. political and regulatory aspects of veterinary antibiotics use in europeMerial EMEA
 
Phytothreats WP3 overview
Phytothreats WP3 overviewPhytothreats WP3 overview
Phytothreats WP3 overview
Forest Research
 
Workshop introduction 4 october
Workshop introduction 4 octoberWorkshop introduction 4 october
Workshop introduction 4 october
Forest Research
 
Slideshow
SlideshowSlideshow
Slideshow
kj0008
 
Slideshow
SlideshowSlideshow
Slideshowkj0008
 
Slideshow
SlideshowSlideshow
Slideshowkj0008
 
One healthoct17 slideshare
One healthoct17 slideshareOne healthoct17 slideshare
One healthoct17 slideshare
Nicola Fawcett
 
MongoDB World 2016: Building the internet of Living Things with MongoDB
MongoDB World 2016: Building the internet of Living Things with MongoDBMongoDB World 2016: Building the internet of Living Things with MongoDB
MongoDB World 2016: Building the internet of Living Things with MongoDB
MongoDB
 
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
Society for Microbiology and Infection care
 
Innovation: managing risk, not avoiding it - evidence and case studies
Innovation: managing risk, not avoiding it - evidence and case studiesInnovation: managing risk, not avoiding it - evidence and case studies
Innovation: managing risk, not avoiding it - evidence and case studiesbis_foresight
 
SMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conferenceSMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conference
Dale Butler
 
P-163 Superbugs & Superdrugs
P-163 Superbugs & SuperdrugsP-163 Superbugs & Superdrugs
P-163 Superbugs & SuperdrugsWarka Ghirmai
 
Beth Purse & Dan Chapman wp3 Nov 2018
Beth Purse & Dan Chapman wp3 Nov 2018Beth Purse & Dan Chapman wp3 Nov 2018
Beth Purse & Dan Chapman wp3 Nov 2018
Forest Research
 
Local actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistanceLocal actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistance
UKFacultyPublicHealth
 

Similar to Dstl Medical Countermeasures for Dangerous Pathogens (20)

The code of conduct the IPT initiative
The code of conduct the IPT initiativeThe code of conduct the IPT initiative
The code of conduct the IPT initiative
 
Impact Through Innovation: The Wellcome Sanger Institute
Impact Through Innovation: The Wellcome Sanger InstituteImpact Through Innovation: The Wellcome Sanger Institute
Impact Through Innovation: The Wellcome Sanger Institute
 
PM Briefings from 9 Feb 2016 Innovation Network event
PM Briefings from 9 Feb 2016 Innovation Network eventPM Briefings from 9 Feb 2016 Innovation Network event
PM Briefings from 9 Feb 2016 Innovation Network event
 
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
Dr. Alex Morrow - Perspectives on the development of global efforts for disea...
 
Dr. Alex Morrow - Global Coordination of Animal Disease Research
Dr. Alex Morrow - Global Coordination of Animal Disease ResearchDr. Alex Morrow - Global Coordination of Animal Disease Research
Dr. Alex Morrow - Global Coordination of Animal Disease Research
 
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
Dr. Cheryl Stroud - What’s New In Efforts To Provide Information On Antibioti...
 
11. political and regulatory aspects of veterinary antibiotics use in europe
11. political and regulatory aspects of veterinary antibiotics use in europe11. political and regulatory aspects of veterinary antibiotics use in europe
11. political and regulatory aspects of veterinary antibiotics use in europe
 
Phytothreats WP3 overview
Phytothreats WP3 overviewPhytothreats WP3 overview
Phytothreats WP3 overview
 
Workshop introduction 4 october
Workshop introduction 4 octoberWorkshop introduction 4 october
Workshop introduction 4 october
 
Slideshow
SlideshowSlideshow
Slideshow
 
Slideshow
SlideshowSlideshow
Slideshow
 
Slideshow
SlideshowSlideshow
Slideshow
 
One healthoct17 slideshare
One healthoct17 slideshareOne healthoct17 slideshare
One healthoct17 slideshare
 
MongoDB World 2016: Building the internet of Living Things with MongoDB
MongoDB World 2016: Building the internet of Living Things with MongoDBMongoDB World 2016: Building the internet of Living Things with MongoDB
MongoDB World 2016: Building the internet of Living Things with MongoDB
 
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
 
Innovation: managing risk, not avoiding it - evidence and case studies
Innovation: managing risk, not avoiding it - evidence and case studiesInnovation: managing risk, not avoiding it - evidence and case studies
Innovation: managing risk, not avoiding it - evidence and case studies
 
SMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conferenceSMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conference
 
P-163 Superbugs & Superdrugs
P-163 Superbugs & SuperdrugsP-163 Superbugs & Superdrugs
P-163 Superbugs & Superdrugs
 
Beth Purse & Dan Chapman wp3 Nov 2018
Beth Purse & Dan Chapman wp3 Nov 2018Beth Purse & Dan Chapman wp3 Nov 2018
Beth Purse & Dan Chapman wp3 Nov 2018
 
Local actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistanceLocal actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistance
 

More from warwick_amr

Fragments for drug discovery and chemical biology
Fragments for drug discovery and chemical biologyFragments for drug discovery and chemical biology
Fragments for drug discovery and chemical biology
warwick_amr
 
Discovering Diverse Chemical Starting Points
Discovering Diverse Chemical Starting PointsDiscovering Diverse Chemical Starting Points
Discovering Diverse Chemical Starting Points
warwick_amr
 
Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapy
warwick_amr
 
Why Novel Antibacterial Discovery is so Hard
Why Novel Antibacterial Discovery is so HardWhy Novel Antibacterial Discovery is so Hard
Why Novel Antibacterial Discovery is so Hard
warwick_amr
 
The SHIELD Consortium
The SHIELD ConsortiumThe SHIELD Consortium
The SHIELD Consortium
warwick_amr
 
AMR Collaborative Grants at the University of Bristol
AMR Collaborative Grants at the University of BristolAMR Collaborative Grants at the University of Bristol
AMR Collaborative Grants at the University of Bristol
warwick_amr
 
New Directions in Structural Biology at Diamond
New Directions in Structural Biology at DiamondNew Directions in Structural Biology at Diamond
New Directions in Structural Biology at Diamond
warwick_amr
 
Structure-guided Design in the Discovery of Antimicrobials
Structure-guided Design in the Discovery of AntimicrobialsStructure-guided Design in the Discovery of Antimicrobials
Structure-guided Design in the Discovery of Antimicrobials
warwick_amr
 
Chemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
Chemical Evolution of B Lactams to Keep Pace with Bacterial ResistanceChemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
Chemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
warwick_amr
 
SWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR CollaborativeSWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR Collaborative
warwick_amr
 
On the Edge of the Abyss
On the Edge of the AbyssOn the Edge of the Abyss
On the Edge of the Abyss
warwick_amr
 

More from warwick_amr (11)

Fragments for drug discovery and chemical biology
Fragments for drug discovery and chemical biologyFragments for drug discovery and chemical biology
Fragments for drug discovery and chemical biology
 
Discovering Diverse Chemical Starting Points
Discovering Diverse Chemical Starting PointsDiscovering Diverse Chemical Starting Points
Discovering Diverse Chemical Starting Points
 
Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapy
 
Why Novel Antibacterial Discovery is so Hard
Why Novel Antibacterial Discovery is so HardWhy Novel Antibacterial Discovery is so Hard
Why Novel Antibacterial Discovery is so Hard
 
The SHIELD Consortium
The SHIELD ConsortiumThe SHIELD Consortium
The SHIELD Consortium
 
AMR Collaborative Grants at the University of Bristol
AMR Collaborative Grants at the University of BristolAMR Collaborative Grants at the University of Bristol
AMR Collaborative Grants at the University of Bristol
 
New Directions in Structural Biology at Diamond
New Directions in Structural Biology at DiamondNew Directions in Structural Biology at Diamond
New Directions in Structural Biology at Diamond
 
Structure-guided Design in the Discovery of Antimicrobials
Structure-guided Design in the Discovery of AntimicrobialsStructure-guided Design in the Discovery of Antimicrobials
Structure-guided Design in the Discovery of Antimicrobials
 
Chemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
Chemical Evolution of B Lactams to Keep Pace with Bacterial ResistanceChemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
Chemical Evolution of B Lactams to Keep Pace with Bacterial Resistance
 
SWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR CollaborativeSWON Alliance Cross Council AMR Collaborative
SWON Alliance Cross Council AMR Collaborative
 
On the Edge of the Abyss
On the Edge of the AbyssOn the Edge of the Abyss
On the Edge of the Abyss
 

Recently uploaded

platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 

Recently uploaded (20)

platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 

Dstl Medical Countermeasures for Dangerous Pathogens

  • 1. Medical countermeasures for dangerous pathogens Andrew Scott, PhD UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 1
  • 2. Corporate information ‘The Defence Science and Technology Laboratory ensures that innovative science and technology contribute to the defence and security of the UK’ •Identify and monitor national security risks and opportunities •Protect the UK and our interests at home, at our border, and internationally, in order to address physical and electronic threats from state and non-state sources UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 2
  • 3. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 Portsdown West Porton Down Fort Halstead Corporate information 3
  • 4. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 Analysis CBR Systems C4ISR Counter Terrorism and Security Cyber Human Capability Integrated Survivability Weapons Corporate capabilities 4
  • 5. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 Corporate capabilities Analysis CBR Systems C4ISR Counter Terrorism and Security Cyber Human Capability Integrated Survivability Weapons ‘Provides an integrated Chemistry, Biology, Radiation and Medical Sciences capability’ CBR Division 54
  • 6. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 CBR Division Modelling, hazard assessment, advice Physical protection Decontamination and disposal Detection and diagnosisMedical countermeasures 6
  • 7. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 7 Biodefence pathogens •Intra-cellular pathogens •More serious disease if inhaled •Symptoms are generic •Insensitive to antibiotics •Treatment is prolonged / requires IV administration Tularaemia Melioidosis Glanders Plague Ebola Anthrax
  • 8. © Crown copyright 2016 Dstl 28 September 2016 UK OFFICIAL •Establish an in-depth knowledge of each biological agent •Develop novel medical countermeasures active against biological warfare (BW) agents •Test the effectiveness of those countermeasures in the most appropriate in vitro and in vivo models. BW MedCM Programme 8
  • 9. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 Microbiology group •Containment Level 2, 3 and 4 laboratories •Handling and manipulation of high-containment pathogens •Animal models of disease 9
  • 10. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 10 Bio Medical Countermeasures Projects BROAD Target discovery and early stage progression of small molecule MedCMs AMIC Engagement with industry and evaluation of more developed candidate MedCMs iMAT Development of key infection models and progression of non traditional therapies
  • 11. Broad-spectrum antimicrobials © Crown copyright 2016 Dstl 28 September 2016 • Conduct fundamental research into the biology of biothreat agents • Stimulate development of novel antimicrobials against novel targets • Align defence needs with public health UK OFFICIAL 11
  • 12. Transposon-Directed mutagenesis – Generation of super-saturated transposon libraries Insertion-site Sequencing – Uses next-gen sequencing technology – Sequence all mutants present within one experiment • T • I UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 TraDIS KanR KanR Transposase Random insertion and gene tagged Transposon Gene B = essential bacteria dies Gene B = non-essential bacteria survives 12 Transposome complex
  • 13. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 Moule et al. (2014) Mbio 5: e00926-13 TraDIS • Absence of insertions 13
  • 14. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 TraDIS Burkholderia pseudomallei Yersinia pestis Francisella tularensis Yp Ft Bp • Conservation across other biothreat pathogens • Conservation across ESKAPEE pathogens • Identification of human homologues • Informatics (druggability, assay availability, previous development) 148 targets to exploit 148 14
  • 15. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 TraDIS for disease related targets 15 • Library of mutants • Infection • Recover bacteria Gene A Gene B Gene C Gene D Gene E Gene A Gene B Gene C Gene D Gene E Quantitative sequencing Quantitative sequencing
  • 16. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 16 284 genes negatively selected at 24 hours TraDIS for disease related targets
  • 17. Next steps… © Crown copyright 2016 Dstl 28 September 2016 UK OFFICIAL 17 Validate relevance in disease Understand target function target in the pathogen Generate tools to support future drug discovery efforts Norville et al. (2011) Infect. Imm. 79, 4299-4307Custodio et al. (2016) Mol. Micro. doi: 10.1111/mmi.13531. [Epub ahead of print]
  • 18. UK OFFICIAL© Crown copyright 2016 Dstl 28 September 2016 18 Bio Medical Countermeasures Projects BROAD Target discovery and early stage progression of small molecule MedCMs AMIC Engagement with industry and evaluation of more developed candidate MedCMs iMAT Development of key infection models and progression of non traditional therapies
  • 19. © Crown copyright 2016 Dstl 28 September 2016 UK OFFICIAL 19 Summary Stimulating target development Pulling compounds through

Editor's Notes

  1. Summary for whole project